N🟁N

CTS Electronics Manufacturing Solutions Awarded New Contract from a Major Medical Orthopedic Firm

  //science-technology.news-articles.net/content/2 .. ntract-from-a-major-medical-orthopedic-firm.html
  Published in Science and Technology on Tuesday, August 30th 2011 at 6:46 GMT by Market Wire
          ^{🞛 This publication is a summary or evaluation of another publication}

ELKHART, Ind.--([ BUSINESS WIRE ])--CTS Corporation (NYSE: CTS) a leading supplier of electronics manufacturing services, today announced that CTS EMS has been awarded a new production program to provide printed circuit board assemblies and high-level assemblies for a leading global medical orthopedic firm.

CTS EMS will provide complex mechanical assemblies for a new type of instrument used in orthopedic surgery. These FDA approved instruments will be manufactured in CTSa™ New Hampshire facility. Shipments from this award are expected to begin in 2012 with initial revenues of approximately $3 million growing to approximately $14 million in 2013.

This award supports CTSa™ strategy in targeting key medical, defense and aerospace and industrial markets for its EMS product portfolio.

About CTS EMS

CTS EMS is a turnkey provider of manufacturing solutions to customers in a range of electronics equipment markets. With global manufacturing facilities in North America, Europe and Asia, a broad product offering and a complete range of turnkey services, CTS is the ideal choice for an OEM seeking customized product solutions from a focused and agile EMS partner.

About CTS

CTS is a leading designer and manufacturer of electronic components and sensors and a provider of electronics manufacturing services (EMS) to OEMs in the automotive, communications, medical, defense and aerospace, industrial and computer markets. CTS manufactures products in North America, Europe and Asia. CTS' stock is traded on the NYSE under the ticker symbol "CTS.a To find out more, visit the CTS Web site at [ www.ctscorp.com ].

Safe Harbor Statement

This press release contains statements that are, or may be deemed to be, forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to, any financial or other guidance, statements that reflect our current expectations concerning future results and events and any other statements that are not based solely on historical fact. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof and are based on various assumptions as to future events, the occurrence of which necessarily are subject to uncertainties. These forward-looking statements are made subject to risks, uncertainties and other factors, which could cause our actual results, performance or achievements to differ materially from those presented in the forward-looking statements, including, without limitation: changes in the economy generally and in respect to the businesses in which CTS operates; rapid technological change; general market conditions in the automotive, communications, and computer industries, as well as conditions in the industrial, defense and aerospace, and medical markets; reliance on key customers; unanticipated natural or other events such as the Japan earthquake; the ability to protect our intellectual property; pricing pressures and demand for our products; and risks associated with our international operations, including trade and tariff barriers, exchange rates and political and geographical risks. For more detailed information on the risks and uncertainties associated with CTSa™ business, see the reports CTS files with the SEC available at [ http://www.ctscorp.com/investor_relations/investor.htm ]. CTS undertakes no obligation to publicly update its forward-looking statements to reflect new information or events or circumstances that arise after the date hereof, including market or industry changes.